-
Symbol
-
DMAC on Nasdaq
-
Investment type
-
Equity / Voting Common Shares, no par value
-
Latest Disclosed Ownership
-
7.76M shares
-
Security Ownership
-
15%
Trill AB ownership in DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC)
2025-09-04 - Trill AB has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.76M shares of DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC).
This represents 15% percent ownership of the company.
In their previous filing dated 2025-07-30, TRILL AB had reported owning 6.76M shares, indicating an increase of 14.8% percent.